Search Results

You are looking at 151 - 160 of 1,090 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access


NCCN Affiliate Research Consortium Offers Community Cancer Centers Cutting-Edge Research Opportunities The NCCN Oncology Research Program (ORP) has established the NCCN Affiliate Research Consortium (ARC). The NCCN ARC’s primary goal is to

Full access

Point: The Power of Data to (Mis)Guide Policy to Improve Cancer Health Equity

Melissa A. Simon, Laura S. Tom, and XinQi Dong

policymakers, other leaders, and, most importantly, communities, including those who are differentially impacted by these messages. Our concern with this article is that in the absence of additional angles and levels of analyses, these ecological data provide

Full access

QIM22-201: Experiences With Cancer Diagnosis and Treatment in Rural Nebraska: Qualitative Focus Group Analysis

Kendra L. Ratnapradipa, Jordan Ranta, Krishtee Napit, Lady Beverly Luma, Danae Dinkel, Tamara Robinson, Laura Schabloske, and Shinobu Watanabe-Galloway

Purpose : To explore rural cancer survivors’ and caregivers’ experiences with diagnosis and treatment, and to identify needed support services. Methods : This collective case study was part of a statewide cancer community health needs

Full access

HSR23-107: Real-World Study of Biomarker Testing and Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in the United States (US): A Physician Survey

Sabine Oskar, Jeri Kim, Alicia Gayle, Chloe Middleton-Dalby, and Himani Aggarwal

testing and treatment decision-making. Results: Of 100 HCPs, 45% were urologists, 45% oncologists, and 10% pathologists. About 64% HCPs were in community practices and 30% in academic centers. HCPs in academic centers reported a median of 70% (IQR=50

Full access

Highlights of the NCCN Oncology Research Program

underserved population with high lung cancer mortality rates. We propose a pathway for lung cancer screening (LCS) and care coordination using a technology-empowered, community-based lung cancer navigator. This project builds on an ongoing partnership between

Full access

HSR22-128: Patient-Level Barriers to Surveillance for Hepatocellular Carcinoma Among Patients With Chronic Liver Disease From the Provider Perspective

Eliza Wright Beal, Leva Gorji, Jaclyn Volney, Lindsey Sova, Ann McAlearney, and Allan Tsung

invite primary care providers from the Departments of Internal Medicine and Family and Community Medicine and specialty providers from the Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, to participate. A semi

Full access

HSR21-062: Real-World Study of BRCA1/2 Mutation (BRCA1/2mut) Testing Among Adult Patients (pts) With HER2− Advanced Breast Cancer (ABC) in the US

Reshma Mahtani, Alex Niyazov, MPH; Katie Lewis, Lucy Massey, Alex Rider, Bhakti Arondekar, and Michael Lux

[HR+/HER2− vs triple-negative breast cancer (TNBC)], practice setting (academic vs community) and type of BRCA1/2 mut test and compared via Fisher’s exact tests. Results: Overall, 407 pts were included; the mean age was 64.2 years, and 99% were

Full access


. Continued communication between NCCN, NCCN Member Institutions, users of NCCN products and services, community, lay and professional organizations, providers, payers, and industry will serve us all well. Please never hesitate to contact those of us at NCCN

Full access

QIM23-146: Using a Multi-Modal Approach in Addressing Identified Barriers to Improve Lung Cancer Screening in Northeast Georgia—An Interim Report

Swathi Kanakamedala, Andria Caton, and Shivang Umesh Danak

weekly. We used a multi-modal approach of educational patient flyers, provider reference guides, and community outreach events. We also improved EMR documentation of smoking history by participating in the nationwide Just Ask campaign. Patient flyers

Full access

BPI24-017: Optimizing the Implementation of New Therapies in Multiple Myeloma

Kirollos Hanna, Craig Emmitt Cole, David Vesole, Mary Stanley, Kimberly Demirhan, Latha Shivakumar, and Elana Plotkin

Background: Treatment regimens for multiple myeloma have expanded significantly over the last decade and have improved outcomes in patients. This expansion has created knowledge and practice gaps among community oncology providers in